The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A proposed new model for prognostic stratification of poor-risk patients with metastatic renal cell carcinoma (mRCC) in the era of targeted therapy.
Daniele Santini
No relevant relationships to disclose
Matteo Santoni
No relevant relationships to disclose
Ugo De Giorgi
No relevant relationships to disclose
Stefano Iacobelli
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose
Gaetano Facchini
No relevant relationships to disclose
Luca Galli
No relevant relationships to disclose
Giuseppe di Lorenzo
No relevant relationships to disclose
Giuseppe Badalamenti
No relevant relationships to disclose
Francesco Maria Guida
No relevant relationships to disclose
Alessandra Felici
No relevant relationships to disclose
Paolo Marchetti
No relevant relationships to disclose
Roberto Iacovelli
No relevant relationships to disclose
Umberto Basso
No relevant relationships to disclose
Vincenzo Adamo
No relevant relationships to disclose
Flavia Longo
No relevant relationships to disclose
Francesco Massari
No relevant relationships to disclose
Joan Carles
No relevant relationships to disclose
Giuseppe Tonini
No relevant relationships to disclose
Michele Milella
No relevant relationships to disclose